APPLICATION OF RECOMBINANT GANODERMA LUCIDUM IMMUNOMODULATORY PROTEIN (RLZ-8) IN PREPARATION OF MEDICINE TO TREAT OSTEOPOROSIS

摘要

Disclosed in the present invention is an application of recombinant ganoderma lucidum immunomodulatory protein (rLZ-8) in the preparation of medicine to treat osteoporosis. The present invention established a rat osteoporosis protective effect and reversal effect model, and administered treatment through rLZ-8 medicine; the experiment results demonstrate that rLZ-8 greatly increases bone mineral density, and effectively modulates metabolism-related serological indicators.